Published in Contrast Media Mol Imaging on November 21, 2010
Fe3O4@organic@Au: core-shell nanocomposites with high saturation magnetisation as magnetoplasmonic MRI contrast agents. Chem Commun (Camb) (2010) 1.02
Scaling Laws at the Nano Size: The Effect of Particle Size and Shape on the Magnetism and Relaxivity of Iron Oxide Nanoparticle Contrast Agents. J Mater Chem B Mater Biol Med (2013) 0.92
A responsive particulate MRI contrast agent for copper(I): a cautionary tale. Dalton Trans (2012) 0.85
A magnetoplasmonic imaging agent for copper(I) with dual response by MRI and dark field microscopy. ACS Nano (2013) 0.77
Magnetoluminescent light switches--dual modality in DNA detection. J Am Chem Soc (2013) 0.77
Functional nanoparticles for magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.77
Fabricating Water Dispersible Superparamagnetic Iron Oxide Nanoparticles for Biomedical Applications through Ligand Exchange and Direct Conjugation. Nanomaterials (Basel) (2016) 0.77
Single molecular weight discrete PEG compounds: emerging roles in molecular diagnostics, imaging and therapeutics. Expert Rev Mol Diagn (2013) 0.76
Approach to Rapid Synthesis and Functionalization of Iron Oxide Nanoparticles for High Gene Transfection. ACS Appl Mater Interfaces (2016) 0.75
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. Chem Rev (1999) 12.52
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev (2008) 8.23
Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater (2004) 6.19
Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc (2004) 5.97
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol (2005) 5.60
Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology (1990) 3.50
Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett (2008) 2.92
Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging (1995) 2.67
Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed Engl (2008) 2.59
Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. J Am Chem Soc (2004) 2.54
Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res (2008) 2.37
Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging (2009) 1.66
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomedicine (2007) 1.21
Reactive nature of dopamine as a surface functionalization agent in iron oxide nanoparticles. J Am Chem Soc (2007) 1.13
Functionalization of magnetic nanoparticles with organic molecules: loading level determination and evaluation of linker length effect on immobilization. Chirality (2008) 0.89
Water relaxation by SPM particles: neglecting the magnetic anisotropy? A caveat. J Magn Reson Imaging (2001) 0.89
T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): theory and experiment. Acad Radiol (1998) 0.84
Next generation, high relaxivity gadolinium MRI agents. Bioconjug Chem (2005) 2.20
Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes. Inorg Chem (2003) 1.69
Insertion of a bulky rhodium complex into a DNA cytosine-cytosine mismatch: an NMR solution study. J Am Chem Soc (2007) 1.21
Principles of responsive lanthanide-based luminescent probes for cellular imaging. Anal Bioanal Chem (2009) 1.13
Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity. J Am Chem Soc (2011) 1.11
A bulky rhodium complex bound to an adenosine-adenosine DNA mismatch: general architecture of the metalloinsertion binding mode. Biochemistry (2009) 1.10
Fe3O4@organic@Au: core-shell nanocomposites with high saturation magnetisation as magnetoplasmonic MRI contrast agents. Chem Commun (Camb) (2010) 1.02
Mineralogy of iron microbial mats from loihi seamount. Front Microbiol (2012) 0.99
Scaling Laws at the Nano Size: The Effect of Particle Size and Shape on the Magnetism and Relaxivity of Iron Oxide Nanoparticle Contrast Agents. J Mater Chem B Mater Biol Med (2013) 0.92
A highly selective luminescent sensor for the time-gated detection of potassium. J Am Chem Soc (2009) 0.87
Basis for sensitive and selective time-delayed luminescence detection of hydroxyl radical by lanthanide complexes. Inorg Chem (2013) 0.83
Sensitive and selective time-gated luminescence detection of hydroxyl radical in water. Chem Commun (Camb) (2010) 0.79
A ratiometric probe for the selective time-gated luminescence detection of potassium in water. Chem Commun (Camb) (2010) 0.79
Effect of oxidative stress on the growth of magnetic particles in Magnetospirillum magneticum. Int Microbiol (2009) 0.78
Magnetoluminescent light switches--dual modality in DNA detection. J Am Chem Soc (2013) 0.77
A magnetoplasmonic imaging agent for copper(I) with dual response by MRI and dark field microscopy. ACS Nano (2013) 0.77
Inferred time- and temperature-dependent cation ordering in natural titanomagnetites. Nat Commun (2013) 0.75
Effect of lanthanide complex structure on cell viability and association. Inorg Chem (2014) 0.75